Concepedia

H. Siendt

HS

Statistics

Publications

3

Citations

145

H-Index

3

Active since

2005

Affiliations

Santhera Pharmaceuticals (Switzerland)(Current)

H. Siendt is an author at Santhera Pharmaceuticals (Switzerland) specializing in molecular pharmacology, dystrophin deficiency, and calpain-mediated proteolysis.

Publications per year

2005–2011

3

Publications

3

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Robert Dallmann, Philipp Weyermann, Corinne Anklin et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 55 citations · Full text

, , +8

Effect of calpain and proteasome inhibition on Ca <sup>2+</sup> ‐dependent proteolysis and muscle histopathology in the <i>mdx</i> mouse

Alexandre Briguet, Michael A. Erb, I. Courdier-Fruh et al. · The FASEB Journal · 2008 · 53 citations

, , +16

Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy

Cyrille Lescop, Holger Herzner, H. Siendt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 37 citations · Full text

, , +10

1–3 of 3